This study aims to investigate the potential role of the ferroptosis pathway in the pathogenesis and clinical course of Alopecia Areata (AA). Serum concentrations of two key ferroptosis biomarkers-Glutathione Peroxidase 4 (GPX4), a primary antioxidant enzyme protecting against lipid peroxidation, and Malondialdehyde (MDA), a major end-product of lipid membrane damage-will be quantitatively measured using Enzyme-Linked Immunosorbent Assay (ELISA) kits.
A total of 156 participants will be enrolled, consisting of 104 patients diagnosed with Alopecia Areata (subdivided into acute and chronic cohorts) and 52 age- and sex-matched healthy controls. Serum biomarker levels will be statistically compared among the groups to determine their diagnostic value. Furthermore, these biomarker levels will be correlated with clinical disease extension evaluated via the Severity of Alopecia Tool (SALT) score and objective trichoscopic activity findings (such as black dots, yellow dots, and exclamation mark hairs). The ultimate goal of this cross-sectional study is to evaluate whether serum GPX4 and MDA can serve as reliable objective biomarkers for monitoring disease severity, staging, and trichoscopic activity in Alopecia Areata management.The ultimate goal of this cross-sectional study is to evaluate whether serum GPX4 and MDA can serve as reliable objective biomarkers for monitoring disease severity, staging, and trichoscopic activity in Alopecia Areata management.
Inclusion Criteria:
Exclusion Criteria:
kayaeselin@gmail.com+905330257301
Patients aged 18-65 formally diagnosed with Alopecia Areata, presenting with active hair loss or new patch formations within the last 6 months.
Patients aged 18-65 formally diagnosed with Alopecia Areata, presenting with stable hair loss patches for at least 6 months with no signs of active shedding.
Age- and sex-matched healthy volunteers with no personal or family history of alopecia, and no active systemic inflammatory, metabolic, or autoimmune conditions.
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata
Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
The Role of Gut and Skin Microbiota in Alopecia Areata
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
For an Investigator-led Hair Study Comparing Between Healthy and Hair Loss Volunteers
Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata